KLKristina S. Lyngso

Kristina S. Lyngso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kristina S. Lyngso has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Pernille B. L. Hansen

    Department of Cardiovascular and Renal Research, Institute of Molecular Medicine University of Southern Denmark Odense Denmark

    3 shared publications
  • Pernille B. Laerkegaard Hansen

    Department of Cardiovascular and Renal Research, University of Southern Denmark, Denmark

    3 shared publications
  • Anne D. Thuesen

    Cardiovascular and Renal Research, University of Southern Denmark, J. B. Winsløwsvej 21, 3., 5000, Odense C, Denmark

    2 shared publications
  • Jane Stubbe

    Cardiovascular and Renal Research Unit, Institute for Molecular Medicine, University of Southern Denmark, 5230 Odense, Denmark

    2 shared publications
  • Andreas Papapetropoulos

    Laboratory of Pharmacology, Department of Pharmacy National and Kapodistrian University of Athens Athens Greece

    1 shared publication
  • Antonio Boza-Serrano

    Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Spain

    1 shared publication

Latest Publications

  • Open Access

    Inhibition of cystathionine‐gamma lyase dampens vasoconstriction in mouse and human intracerebral arterioles

    by Maria Peleli, Kristina S. Lyngso, Frantz Rom Poulsen, Pernille B. L. Hansen, Andreas Papapetropoulos, Jane Stubbe

    Aim: In extracerebral vascular beds cystathionine‐gamma lyase (CSE) activity plays a vasodilatory role but the role of this hydrogen sulfide (H2S) producing enzyme in the intracerebral arterioles remain poorly understood. We hypothesized a similar function in the intracerebral arterioles.Methods: Intracerebral arterioles were isolated from wild type C57BL/6J mouse (9–12 months old) brains and from human brain biopsies. The function (contractility and secondary dilatation) of the intracerebral arterioles was tested ex vivo by pressure myography using a perfusion set‐up. Reverse transcription polymerase chain reaction was used for detecting CSE expression.Results: CSE is expressed in human and mouse intracerebral arterioles. CSE inhibition with L‐propargylglycine (PAG) significantly dampened the K+‐induced vasoconstriction in intracerebral arterioles of both species (% of maximum contraction: in human control: 45.4 ± 2.7 versus PAG: 27 ± 5.2 and in mouse control: 50 ± 1.5 versus PAG: 33 ± 5.2) but did not affect the secondary dilatation. This effect of PAG was significantly reversed by the H2S donor sodium hydrosulfide (NaSH) in human (PAG + NaSH: 38.8 ± 7.2) and mouse (PAG + NaSH: 41.7 ± 3.1) arterioles, respectively. The endothelial NO synthase (eNOS) inhibitor, Nω‐Nitro‐l‐arginine methyl ester (L‐NAME), and the inhibitor of soluble guanylate cyclase (sGC), 1H‐[1,2,4]oxadiazolo[4,3‐a]quinoxalin‐1‐one (ODQ) reversed the effect of PAG on the K+‐induced vasoconstriction in the mouse arterioles and attenuated the K+‐induced secondary dilatation significantly.Conclusion: CSE contributes to the K+‐induced vasoconstriction via a mechanism involving H2S, eNOS, and sGC whereas the secondary dilatation is regulated by eNOS and sGC but not by CSE.


  • Endothelial mineralocorticoid receptor ablation confers protection towards endothelial dysfunction in experimental diabetes in mice

    by Kristina S. Lyngsø, Boye L. Jensen, Pernille B. L. Hansen, Henrik Dimke

    Aim: With diabetes comes a significant risk of macrovascular and microvascular complications. Circulating aldosterone levels increase in patients with diabetes. Aldosterone can directly affect vascular function via activation of the mineralocorticoid receptor (MR). We hypothesized that aldosterone via endothelial MR impairs endothelial function in a murine model of experimental diabetes.Method: Endothelial cell‐specific mineralocorticoid receptor knockout MRflox/flox; Tie2‐Cre mice (ECMR‐KO) and wild‐type FVB littermates were subjected to an experimental type‐1 diabetic model by low dose streptozotocin injections (55mg/kg/day) for five consecutive days. After 10 weeks of diabetes, second‐order mesenteric resistance arteries were perfused ex vivo to evaluate vessel contractility and endothelial function. The effect of ex vivo incubation with aldosterone with and without the antagonist, spironolactone was determined.Results: Diabetic ECMR‐KO and wild‐type mice had similar, elevated, plasma aldosterone concentration while only diabetic wild‐type mice displayed elevated urine albumin excretion and cardiac and kidney hypertrophy at 10 weeks. There were no differences in contraction (Emax and EC50) to thromboxane receptor agonist (U46619) and elevated K+ between groups. Wild‐type diabetic mice showed impaired acetylcholine (ACh)‐dependent relaxation, while diabetic ECMR‐KO mice had intact ACh‐mediated relaxation. Aldosterone incubation ex vivo impaired ACh mediated relaxation and rendered responses similar to diabetic WT arteries. Direct, ex vivo aldosterone effects were absent in ECMR‐KO animals. Ex vivo inhibitory effects of aldosterone on endothelial relaxation in arteries from WT were abolished by spironolactone.Conclusion: These findings show that endothelial cell mineralocorticoid receptor activation accounts for diabetes‐induced systemic endothelial dysfunction in experimental diabetes and may explain the cardiovascular protection by MR antagonists in diabetes.


  • Open Access

    Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice

    by Mateusz G. Adamski, Magdalena Sternak, Tasnim Mohaissen, Dawid Kaczor, Joanna M. Wierońska, Monika Malinowska, Iwona Czaban, Katarzyna Byk, Kristina S. Lyngsø, Kamil Przyborowski, et al.

    Background: Although advanced heart failure ( HF ) is a clinically documented risk factor for vascular cognitive impairment, the occurrence and pathomechanisms of vascular cognitive impairment in early stages of HF are equivocal. Here, we characterize vascular cognitive impairment in the early stages of HF development and assess whether cerebral hypoperfusion or prothrombotic conditions are involved. Methods and Results: Tgαq*44 mice with slowly developing isolated HF triggered by cardiomyocyte‐specific overexpression of G‐αq*44 protein were studied before the end‐stage HF , at the ages of 3, 6, and 10 months: before left ventricle dysfunction; at the stage of early left ventricle diastolic dysfunction (with preserved ejection fraction); and left ventricle diastolic/systolic dysfunction, respectively. In 6‐ to 10‐month‐old but not in 3‐month‐old Tgαq*44 mice, behavioral and cognitive impairment was identified with compromised blood‐brain barrier permeability, most significantly in brain cortex, that was associated with myelin sheet loss and changes in astrocytes and microglia. Brain endothelial cells displayed increased E‐selectin immunoreactivity, which was accompanied by increased amyloid‐β 1‐42 accumulation in piriform cortex and increased cortical oxidative stress (8‐ OH dG immunoreactivity). Resting cerebral blood flow measured by magnetic resonance imaging in vivo was preserved, but ex vivo NO ‐dependent cortical arteriole flow regulation was impaired. Platelet hyperreactivity was present in 3‐ to 10‐month‐old Tgαq*44 mice, but it was not associated with increased platelet‐dependent thrombogenicity. Conclusions: We report for the first time that vascular cognitive impairment is already present in the early stage of HF development, even before left ventricle systolic dysfunction. The underlying pathomechanism, independent of brain hypoperfusion, involves preceding platelet hyperreactivity and brain endothelium inflammatory activation.


  • Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice

    by Anne D. Thuesen, Kenneth Andersen, Kristina S. Lyngsø, Mark Burton, Charlotte Brasch-Andersen, Paul M. Vanhoutte, Pernille B. L. Hansen

    Impairment of endothelial function with aging is accompanied by reduced nitric oxide (NO) production. T-type Cav3.1 channels augment nitric oxide and co-localize with eNOS. Therefore, the hypothesis was that T-type channels contribute to the endothelial dysfunction of aging. Endothelial function was determined in mesenteric arteries (perfusion) and aortae (isometric contraction) of young and old wild-type (WT), Cav3.1, and Cav3.2 knockout mice. NO production was measured by fluorescence imaging in mesenteric arteries. With age, endothelium-dependent subsequent dilatation (following depolarization with KCl) of mesenteric arteries was diminished in the arteries of WT mice, unchanged in Cav3.2−/− preparations but increased in those of Cav3.1−/− mice. NO synthase inhibition abolished the subsequent dilatation in mesenteric arteries and acetylcholine-induced relaxations in aortae. NO levels were significantly reduced in mesenteric arteries of old compared to young WT mice. In Cav3.1−/− and Cav3.2−/− preparations, NO levels increased significantly with age. Relaxations to acetylcholine were significantly smaller in the aortae of old compared to young WT mice, while such responses were comparable in preparations of young and old Cav3.1−/− and Cav3.2−/− mice. The expression of Cav3.1 was significantly reduced in aortae from aged compared to young WT mice. The level of phosphorylated eNOS was significantly increased in aortae from aged Cav3.1−/− mice. In conclusion, T-type calcium channel-deficient mice develop less age-dependent endothelial dysfunction. Changes in NO levels are involved in this phenomenon in WT and Cav3.1−/− mice. These findings suggest that T-type channels play an important role in age-induced endothelial dysfunction.


  • Fumarate decreases edema volume and improves functional outcome after experimental stroke

    by Bettina Hjelm Clausen, Louise Lundberg, Minna Yli-Karjanmaa, Nellie Anne Martin, Martina Svensson, Maria Zeiler Alfsen, Simon Bertram Flæng, Kristina Lyngsø, Antonio Boza-Serrano, Helle H. Nielsen, et al.


  • Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?

    by Kristina S. Lyngsø, Kasper Assersen, Emil G. Dalgaard, Ole Skott, Boye L. Jensen, Pernille B. L. Hansen

    Besides the well-known renal effects of aldosterone, the hormone is now known to have direct vascular effects. Clinical observations underline substantial adverse effects of aldosterone on cardiovascular function. The source of systemic circulating aldosterone is the adrenal gland zona glomerulosa cells through stimulus-secretion coupling involving depolarization, opening of L- and T-type calcium channels and aldosterone synthase activation. Local formation and release in peripheral tissues such as perivascular fat is recognized. Where does aldosterone affect the vasculature? Mineralocorticoid receptors (MRs) are present in endothelial and vascular smooth muscle cells, and MR-independent pathways are also involved. The vascular effects of aldosterone are complex, both concentration and temporal and spatial aspects are relevant. The acute response includes vasodilation through endothelial nitric oxide formation and vasoconstrictor effects through endothelial-contracting cyclooxygenase-derived factors and a changed calcium handling. The response to aldosterone can change within the same blood vessels depending on the exposure time and status of the endothelium. Chronic responses involve changed levels of reactive oxygen radicals, endothelial Na-influx and smooth muscle calcium channel expression. Furthermore, perivascular cells for example mast cells have also been suggested to participate in the chronic response. Moreover, the vascular effect of aldosterone depends on the status of the endothelium which is likely the cause of the very different responses to aldosterone and MR treatment observed in human studies going from increased to decreased flow depending on whether the patient had prior cardiovascular disease with endothelial dysfunction or not. A preponderance of constrictor versus dilator responses to aldosterone could therefore be involved in the detrimental vascular actions of the hormone in the setting of endothelial dysfunction and contribute to explain the beneficial action of MR blockers on blood pressure and target organ injury.


  • P/Q‐type and T‐type voltage‐gated calcium channels are involved in the contraction of mammary and brain blood vessels from hypertensive patients

    by Anne D. Thuesen, Kristina S. Lyngsø, Jane Stubbe, Ole Skøtt, Frantz R. Poulsen, Christian Bonde Pedersen, L. M. Rasmussen, Pernille B. L. Hansen

    Aim: Calcium channel blockers are widely used in cardiovascular diseases. Besides L‐type channels, T‐ and P/Q‐type calcium channels are involved in the contraction of human renal blood vessels. It was hypothesized that T‐ and P/Q‐type channels are involved in the contraction of human brain and mammary blood vessels.Methods: Internal mammary arteries from bypass surgery patients and cerebral arterioles from patients with brain tumours with and without hypertension were tested in a myograph and perfusion set‐up.PCRand immunohistochemistry were performed on isolated blood vessels.Results: The P/Q‐type antagonist ω‐agatoxinIVA(10−8 mol L−1) and the T‐type calcium blocker mibefradil (10−7 mol L−1) inhibitedKCl depolarization‐induced contraction in mammary arteries from hypertensive patients with no effect on blood vessels from normotensive patients. ω‐AgatoxinIVAdecreased contraction in cerebral arterioles from hypertensive patients. L‐type blocker nifedipine abolished the contraction in mammary arteries.PCRanalysis showed expression of P/Q‐type (Cav2.1), T‐type (Cav3.1 and Cav3.2) and L‐type (Cav1.2) calcium channels in mammary and cerebral arteries. Immunohistochemical labelling of mammary and cerebral arteries revealed the presence of Cav2.1 in endothelial and smooth muscle cells. Cav3.1 was also detected in mammary arteries.Conclusion: P/Q‐ and T‐type Cavare present in human internal mammary arteries and in cerebral penetrating arterioles. P/Q‐ and T‐type calcium channels are involved in the contraction of mammary arteries from hypertensive patients but not from normotensive patients. Furthermore, in cerebral arterioles P/Q‐type channels importance was restricted to hypertensive patients might lead to that T‐ and P/Q‐type channels could be a new target in hypertensive patients.